Kurs
-1,04%
Likviditet
0,46 MSEK
Kalender
| Tid* | ||
| 2025-02-18 | 08:00 | Bokslutskommuniké 2024 |
| 2024-11-19 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-20 | - | Kvartalsrapport 2024-Q2 |
| 2024-06-07 | - | X-dag ordinarie utdelning CALMA B 0.00 SEK |
| 2024-06-05 | - | Årsstämma |
| 2024-05-21 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-20 | - | Bokslutskommuniké 2023 |
| 2023-12-14 | - | Extra Bolagsstämma 2023 |
| 2023-11-21 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-22 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-23 | - | Kvartalsrapport 2023-Q1 |
| 2023-05-17 | - | X-dag ordinarie utdelning CALMA B 0.00 SEK |
| 2023-05-16 | - | Årsstämma |
| 2023-02-21 | - | Bokslutskommuniké 2022 |
| 2022-11-22 | - | Kvartalsrapport 2022-Q3 |
| 2022-09-22 | - | Extra Bolagsstämma 2022 |
| 2022-08-23 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-24 | - | Kvartalsrapport 2022-Q1 |
| 2022-05-19 | - | X-dag ordinarie utdelning CALMA B 0.00 SEK |
| 2022-05-17 | - | Årsstämma |
| 2022-02-25 | - | Bokslutskommuniké 2021 |
| 2022-02-23 | - | Bokslutskommuniké 2021 |
| 2021-10-29 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-27 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-28 | - | Kvartalsrapport 2021-Q1 |
| 2021-05-19 | - | X-dag ordinarie utdelning CALMA B 0.00 SEK |
| 2021-05-18 | - | Årsstämma |
| 2021-02-26 | - | Bokslutskommuniké 2020 |
| 2020-12-23 | - | Extra Bolagsstämma 2020 |
| 2020-11-25 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-27 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-20 | - | Kvartalsrapport 2020-Q1 |
| 2020-05-15 | - | X-dag ordinarie utdelning CALMA B 0.00 SEK |
| 2020-05-14 | - | Årsstämma |
| 2020-02-28 | - | Bokslutskommuniké 2019 |
| 2019-11-25 | - | Kvartalsrapport 2019-Q3 |
| 2019-11-06 | - | Extra Bolagsstämma 2019 |
| 2019-08-27 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-23 | - | Kvartalsrapport 2019-Q1 |
| 2019-05-10 | - | X-dag ordinarie utdelning CALMA B 0.00 SEK |
| 2019-05-09 | - | Årsstämma |
| 2019-02-28 | - | Bokslutskommuniké 2018 |
| 2018-11-26 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-27 | - | Kvartalsrapport 2018-Q2 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Spotlight |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Calmark Sweden AB (publ) announces today that an order has been received from the Company's distributor in Greece, Prime Biosciences, for the Neo products. Today's order is of less economic importance, but significant in a launch perspective.
As previously disclosed, Calmark has entered into an exclusive distributor agreement with Prime Biosciences. The cooperation between the companies has been going on for some time, and the launch plan has been thoroughly prepared. Today's order shows that end customers have an interest in Calmark's products and that sales operations in Greece are under way.
"Prime Biosciences is a strongly committed distributor, which has already held a large number of meetings and discussions relating to our products with hospital clients. The first order will be delivered to interested end customers shortly," says Magdalena Tharaldsen, Director International Business Development. "I am delighted that work is proceeding swiftly!"
Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.
This disclosure contains information that Calmark Sweden AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 31-05-2022 16:02 CET.
Anna Söderlund, CEO
Telefon: +46 70 214 98 93
E-post: anna.soderlund@calmark.se
www.calmark.se